LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 Amendment to Purchases
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. |
|
| Company dealt in | WILLIS TOWERS WATSON PLC |
|
| Class of relevant security to which the | ORD |
|
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,897,709 |
1.47% |
233,108 |
0.18% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
72,359 |
0.06% |
94,581 |
0.07% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
1,976,168 |
1.53% |
333,789 |
0.26% |
||
|
|
|
|
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit |
Purchase |
2 |
256.2850 USD |
Purchase |
4 |
257.9800 USD |
Purchase |
4 |
257.3500 USD |
Purchase |
10 |
255.3200 USD |
Purchase |
33 |
256.5300 USD |
Purchase |
66 |
256.6781 USD |
Purchase |
82 |
256.1200 USD |
Purchase |
92 |
255.3334 USD |
Purchase |
100 |
254.9200 USD |
Purchase |
100 |
255.0080 USD |
Purchase |
100 |
256.1800 USD |
Purchase |
135 |
255.3464 USD |
Purchase |
140 |
255.5550 USD |
Purchase |
150 |
255.9000 USD |
Purchase |
162 |
256.0728 USD |
Purchase |
200 |
256.8900 USD |
Purchase |
200 |
255.1650 USD |
Purchase |
240 |
255.3487 USD |
Purchase |
300 |
255.5800 USD |
Purchase |
400 |
255.3307 USD |
Purchase |
440 |
255.1330 USD |
Purchase |
500 |
255.3450 USD |
Purchase |
556 |
256.6081 USD |
Purchase |
624 |
257.0070 USD |
Purchase |
700 |
254.9857 USD |
Purchase |
700 |
255.6871 USD |
Purchase |
836 |
255.8816 USD |
Purchase |
1,402 |
255.0100 USD |
Purchase |
2,073 |
256.8778 USD |
Purchase |
2,216 |
256.1178 USD |
Purchase |
2,288 |
256.1445 USD |
Purchase |
2,522 |
256.2692 USD |
Purchase |
2,719 |
255.9627 USD |
Purchase |
3,386 |
255.5641 USD |
Purchase |
4,086 |
255.7388 USD |
Purchase |
4,513 |
256.4314 USD |
Purchase |
4,718 |
255.2218 USD |
Purchase |
5,770 |
255.6502 USD |
Purchase |
6,156 |
256.1104 USD |
Purchase |
6,606 |
255.4358 USD |
Purchase |
7,752 |
255.8503 USD |
Purchase |
13,226 |
256.8070 USD |
Purchase |
27,824 |
255.6000 USD |
Purchase |
32,711 |
255.9868 USD |
Sale |
1 |
256.5200 USD |
Sale |
8 |
257.3500 USD |
Sale |
19 |
256.8800 USD |
Sale |
35 |
256.5128 USD |
Sale |
82 |
256.1200 USD |
Sale |
92 |
257.7300 USD |
Sale |
100 |
256.4800 USD |
Sale |
200 |
256.4750 USD |
Sale |
200 |
255.2350 USD |
Sale |
900 |
257.1711 USD |
Sale |
1,120 |
256.2842 USD |
Sale |
1,305 |
255.5906 USD |
Sale |
1,340 |
256.3016 USD |
Sale |
1,689 |
256.1670 USD |
Sale |
1,722 |
256.2468 USD |
Sale |
1,852 |
256.6095 USD |
Sale |
2,078 |
256.1301 USD |
Sale |
2,674 |
255.6005 USD |
Sale |
3,164 |
256.3502 USD |
Sale |
3,431 |
255.6019 USD |
Sale |
3,678 |
256.3424 USD |
Sale |
3,909 |
256.3519 USD |
Sale |
6,480 |
255.7491 USD |
Sale |
10,000 |
255.1963 USD |
Sale |
21,673 |
255.6000 USD |
Sale |
30,000 |
256.1968 USD |
Sale |
35,176 |
255.9337 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 17 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |